Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Goodbody Health Ltd GDBYF

Healthcare Drug Manufacturers - Specialty & Generic
Goodbody Health Ltd is a wellness company operating in both COVID testing in the United Kingdom and as a vertically integrated cannabinoid CBD company that operates in the United Kingdom and the European Union. It has interests in COVID testing clinics, CBD extraction, wholesale bulk isolate, and distillate sales, retail CBD and white label sales, cannabinoid laboratory testing, and medicinal cannabis research programs.


GREY:GDBYF - Post by User

Goodbody Health Ltd > Dragonfly Litigation
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(0)
•••
Comment by Accrocheon Aug 19, 2020 1:19pm
67 Views
Post# 31429332

RE:Dragonfly Litigation

RE:Dragonfly LitigationWhat is the future for DragonFly? Their ex partner is now a competitor. To whose advantage this termination will it be?
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities